Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy

Upper Limb Function After Intrathecal Baclofen Treatment in Children With Cerebral Palsy

(2011) Francesco Motta et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?

(2010) K Ramstad et al.   ACTA PAEDIATRICA

Botulinumtoxin A treatment in toddlers with cerebral palsy

(2010) K Tedroff et al.   ACTA PAEDIATRICA

THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY

(2010) Dianne J. Russell et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial

(2010) John F McLaughlin et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Development and reliability of a system to classify gross motor function in children with cerebral palsy

(2010) Robert Palisano et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

(2010) M. R. Delgado et al.   NEUROLOGY

Functional Status of Patients With Cerebral Palsy According to the International Classification of Functioning, Disability and Health Model: A 20-Year Follow-Up Study After Selective Dorsal Rhizotomy

(2009) Nelleke G. Langerak et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Experienced Problems of Young Adults With Cerebral Palsy: Targets for Rehabilitation Care

(2009) Channah Nieuwenhuijsen et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Long-term outcomes five years after selective dorsal rhizotomy

(2009) Eva Nordmark et al.   BMC Pediatrics

Long-term effects of botulinum toxin A in children with cerebral palsy

(2009) KRISTINA TEDROFF et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Stability and decline in gross motor function among children and youth with cerebral palsy aged 2 to 21 years

(2009) STEVEN E HANNA et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment

(2009) Anna Ward et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Intrathecal Baclofen Infusion for Ambulant Children With Cerebral Palsy

(2009) Sylvain Brochard et al.   PEDIATRIC NEUROLOGY

Surgical Management of Spasticity in Persons with Cerebral Palsy

(2009) Abigail K. Lynn et al.   PM&R

Development of spasticity with age in a total population of children with cerebral palsy

(2008) Gunnar Hägglund et al.   BMC MUSCULOSKELETAL DISORDERS

Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy

(2008) A. P. Moore et al.   NEUROLOGY